HomeClinical TopicsFDA approves Simponi for ulcerative colitis

FDA approves Simponi for ulcerative colitis

Author(s):

May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe ulcerative colitis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content